Use of β-Blockers in Patients with Reactive Airway Disease [2] (multiple letters)

Annals of Internal Medicine

Volumn 139, Issue 4, 2003, Pages 304-

  Shulan, David J ^a   Katlan, Michael ^a   Lavsky Shulan, Mollie ^b   Salpeter, Shelley R ^c   Ormiston, Thomas M ^c  

^a Certified Allerg/Asthma Consult   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

^c SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO;

ACUTE HEART INFARCTION; AIRWAY OBSTRUCTION; ASTHMA; BETA ADRENERGIC RECEPTOR BLOCKING; BRONCHUS HYPERREACTIVITY; CARDIOSELECTIVITY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE EXACERBATION; DOSE TIME EFFECT RELATION; DRUG SAFETY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LETTER; LONG TERM EXPOSURE; META ANALYSIS; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG CONTRAINDICATION; DRUG EFFECT; FORCED EXPIRATORY FLOW; NOTE; PATHOPHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ASTHMA; FORCED EXPIRATORY FLOW RATES; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 1642502333     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-4-200308190-00020     Document Type: Letter

References (0)